• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磺胺甲氧嗪和磺胺异嘧啶聚合物的生物利用度。

Biological availability of sulfamethoxypyridazine and sulfisomidine polymers.

作者信息

Kassem A A, Tawfik A S, Bayoma S M, Geneidi A S, El-Sharkawy A M

出版信息

Pharmazie. 1981 Dec;36(12):827-30.

PMID:7330085
Abstract

Dissolution rates and apparent solubilities of forms I, II and III of Sulfamethoxypyridazine (1) and forms I and II of sulfisomidine (2) were determined in water at 37 degrees C. The ratios of apparent solubilities of I:II:III for 1 forms and I:II for 2 forms were 1:1.18:1.25 and 1:1.32 respectively. Upon long contact of 2 with water the ratio of II:I decreased. This has been attributed to gradual transformation of 2 from form II to I. Gastrointestinal absorption of form III of 1, in human volunteers, was studied in comparison with the more stable form I. The same study was carried out on forms I and II of 2. Data were correlated and expressed in availability rate constants (K1), applying the one compartment open: model. This and other parameters show that form III of 1 is 1.4 times as much absorbed as form I, and that the availability of the metastable form II of 2 is 1.2 times as much absorbed as the stable form I.

摘要

测定了磺胺甲氧嗪(1)的Ⅰ、Ⅱ、Ⅲ型及磺胺异嘧啶(2)的Ⅰ、Ⅱ型在37℃水中的溶出速率和表观溶解度。1型的Ⅰ:Ⅱ:Ⅲ表观溶解度之比以及2型的Ⅰ:Ⅱ表观溶解度之比分别为1:1.18:1.25和1:1.32。2与水长时间接触后,Ⅱ:Ⅰ的比例降低。这归因于2从Ⅱ型逐渐转变为Ⅰ型。在人体志愿者中,研究了1的Ⅲ型与更稳定的Ⅰ型相比的胃肠道吸收情况。对2的Ⅰ型和Ⅱ型也进行了同样的研究。数据进行了关联,并应用单室开放模型以有效速率常数(K1)表示。该参数及其他参数表明,1的Ⅲ型吸收量是Ⅰ型的1.4倍,2的亚稳Ⅱ型的吸收利用率是稳定Ⅰ型的1.2倍。

相似文献

1
Biological availability of sulfamethoxypyridazine and sulfisomidine polymers.磺胺甲氧嗪和磺胺异嘧啶聚合物的生物利用度。
Pharmazie. 1981 Dec;36(12):827-30.
2
Comparative bioavailability of anhydrous griseofulvin and its chloroform solvate in man.无水灰黄霉素及其氯仿溶剂化物在人体中的相对生物利用度。
Res Commun Chem Pathol Pharmacol. 1975 Jun;11(2):233-43.
3
[Enteral absorption of sulfasomidine depending on age (author's transl)].不同年龄组磺胺二甲嘧啶的肠吸收情况(作者译)
Arzneimittelforschung. 1978;28(5):861-4.
4
[Tubular reabsorption of sulfanilamides in rats].[大鼠中磺胺类药物的肾小管重吸收]
Acta Biol Med Ger. 1971;26(6):1259-60.
5
Comparison of the bioavailability of cyanocobalamin from capsule and liquid dosage forms.胶囊剂型与液体制剂中氰钴胺生物利用度的比较。
Am J Hosp Pharm. 1975 Oct;32(10):1047-9.
6
[Pharmacokinetic model studies on the rat. The single-chamber model of the organism].
Acta Biol Med Ger. 1970;25(1):151-60.
7
[Behavior of sulfanilamides in the body].
Arzneimittelforschung. 1970 Sep;20(9):1171-9.
8
Dissolution kinetics of glibenclamide glass.
Acta Pharm Hung. 1997 Jan;67(1):13-7.
9
Determination of intraluminal theophylline concentrations after oral intake of an immediate- and a slow-release dosage form.
J Pharm Pharmacol. 2005 Aug;57(8):987-96. doi: 10.1211/0022357056631.
10
[Effect of protein binding on the pharmacokinetics of sulfanilamides in rats].[蛋白质结合对大鼠体内磺胺类药物药代动力学的影响]
Acta Biol Med Ger. 1971;27(3):611-7.